Lenzenhuber v. Misonix, Inc.

CourtDistrict Court, E.D. Missouri
DecidedMay 4, 2023
Docket4:23-cv-00197
StatusUnknown

This text of Lenzenhuber v. Misonix, Inc. (Lenzenhuber v. Misonix, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Missouri primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lenzenhuber v. Misonix, Inc., (E.D. Mo. 2023).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI EASTERN DIVISION

C.J. LENZENHUBER, ) ) Plaintiff, ) ) vs. ) Case No. 4:23-CV-197 PLC ) MISONIX, INC. and BIOVENTUS LLC, ) ) Defendants. )

MEMORANDUM AND ORDER

This matter is before the Court on Plaintiff C.J. Lenzenhuber’s “Suggestion of Lack of Jurisdiction” [ECF No. 10], “Amended Suggestion of Lack of Jurisdiction” [ECF No. 11], and Motion to Remand [ECF No. 24]. Prior to Plaintiff filing her Motion to Remand, the Court converted Plaintiff’s “Suggestion of Lack of Jurisdiction” [ECF No. 10] to a Motion to Remand and Plaintiff’s “Amended Suggestion of Lack of Jurisdiction” [ECF No. 11] to an Amended Motion to Remand. [Docket entries for 2/21/2023 for ECF Nos. 10 & 11]. Defendants Misonix, Inc. and Bioventus, LLC oppose remand. For the following reasons, the Court grants Plaintiff’s March 19, 2023 Motion to Remand [ECF No. 24] and denies as moot Plaintiff’s February 21, 2023 Motion to Remand [ECF No. 10] and Amended Motion to Remand [ECF No. 11].1 I. Background

1 There are four additional motions pending that were filed in the State court proceeding before Defendants removed the action to this Court, including a Motion for Leave to Proceed as a Jane Doe [ECF No. 7], Motion to Vacate/Reset a Motion Hearing Date [ECF No. 9], Motion for Default Judgment [ECF No. 16], and Motion to Dismiss [ECF No. 18]. The Court declines to rule on these motions, leaving their resolution for the State court upon remand. On February 21, 2022, Plaintiff filed an eight-count petition against Defendants in the Circuit Court of the City of St. Louis alleging discrimination under the Missouri Human Rights Act, unpaid commissions and wages, and workers’ compensation retaliation under Missouri’s Workers’ Compensation Act, RSMo. § 287.780, (the Act). [ECF No. 5] Plaintiff alleged her claims

arose under Missouri law and that the “action [was] non-removable [under 28 U.S.C. § 1445(c)] because it raises a claim under the Missouri Workers’ Compensation Law.” [ECF No. 5, ¶ 5] On June 30, 2022, Plaintiff served a summons and a copy of the petition on Defendant Bioventus. [ECF No. 1, ¶ 4 & Ex. 1-2, pg. 42-43] On December 8, 2022, Plaintiff served a summons and a copy of the petition on Defendant Misonix. [ECF No. 1, ¶ 5] On December 16, 2022, Defendants filed a motion seeking to dismiss six of Plaintiff’s claims, including her workers’ compensation retaliation claim under the Act. [ECF No. 18] Defendants alleged Plaintiff failed to state a claim under the Act because she did not exercise any rights under the Act, a necessary element of a retaliation claim. [ECF No. 18, 19] Specifically, Defendants argued there was “no possibility for Bioventus to have discriminated on the basis [of

Plaintiff’s exercise of her rights under the Act]” because Plaintiff’s petition “fails to allege she availed herself of medical treatment, filed a workers’ compensation claim, or indicated to anyone at Bioventus she intended to file a workers’ compensation claim.” [ECF No. 19] Defendants alternatively requested that the court sever Plaintiff’s workers’ compensation claim from her remaining claims. [ECF No. 18 & 19] Within their argument for severance, Defendants asserted that the “implication” of Plaintiff’s statement in her petition that the action was non-removable due to her workers’ compensation retaliation claim “is that the claim was joined to the matter specifically for the purpose of avoiding removal, which implication is strengthened by the absence of factual support for the claim[.]” [ECF No. 19, fn. 5] Defendants set a hearing on their motion to dismiss for February 15, 2023. [ECF No. 1-2] On February 14, 2023, Plaintiff’s counsel filed a motion requesting the hearing be reset after he “began experiencing flu-like symptoms” rendering him unable to “safely travel” to the hearing. [ECF No. 1-2] The State court docket sheet reflects that the February 15th hearing was cancelled.

[ECF No. 1-2] On February 17, 2023, Defendants removed the case to this Court asserting diversity jurisdiction pursuant to 28 U.S.C. §1332.2 [ECF No. 1, ¶14] In the notice of removal, Defendants allege the action is removable because Plaintiff fraudulently joined the workers’ compensation retaliation claim in order to avoid federal jurisdiction. [ECF No. 1, ¶¶ 6, fn. 3, 33, 39] Defendants maintain that (1) the “fraudulent nature of Plaintiff’s [workers’ compensation retaliation claim] is clear because Plaintiff alleged the action was non-removable in her petition and (2) Plaintiff’s claim failed as a matter of law because she had not exercised a right under the Act or pled facts

2 In support of diversity jurisdiction, Defendants assert the amount in controversy exceeds $75,000 and there is complete diversity among the parties because Plaintiff is a citizen of Missouri and Defendants are citizens of Delaware and North Carolina. [ECF No. 1, ¶¶ 13-14, 15-18] In the notice of removal, Defendants allege Bioventus, LLC has only one member, Bioventus, Inc, a Delaware corporation “with its principal offices in North Carolina” and “Misonix, Inc. was acquired by Bioventus LLC in October 2021, at which time it became a wholly-owned subsidiary of Bioventus LLC.” [ECF No. 1, ¶16] Defendants maintain in their responsive briefing that the requirements for removal have been met, noting that Plaintiff has not disputed “the diversity of the parties[.]” [ECF No. 22, 28] The Court, however, “may raise the [subject matter jurisdiction] issue…even if the parties do not.” Magee v. Exxon Corp., 135 F.3d 599, 601 (8th Cir. 1998). Here, Defendants have not established diversity jurisdiction because neither the pleadings nor the notice of removal establish the citizenship of Defendant Misonix, Inc. Defendants’ assertion that Misonix, Inc. became a “wholly-owned subsidiary of Bioventus, LLC” in October 2021 is irrelevant for jurisdictional purposes because a corporation’s citizenship is not determined by the citizenship of its stockholders. Instead, a corporation is a citizen of the State where it is incorporated and the State where it has its principal place of business. 28 U.S.C. § 1332(c)(1). Defendants’ notice of removal does not set forth Misonix, Inc.’s place of incorporation or its principal place of business. Although Plaintiff’s petition alleged that Misonix, Inc “is a New York corporation with a principal place of business in…New York” [ECF No. 5, ¶ 2], Defendants denied these allegations in their answer without explanation. [ECF No. 8, ¶ 2] Because the record does not demonstrate Misonix, Inc.’s citizenship, Defendants have failed to establish diversity of citizenship among the parties. Typically, the Court would have issued a show cause order to provide Defendants the opportunity to attempt to cure the deficiency. The Court elected not to do so in this case because amendment of the notice of removal would be futile in light of the Court’s finding that Defendants’ removal was untimely. showing any alleged exercise of her rights under the Act was a motivating factor in her termination. [ECF No. 1, ¶¶ 33, 34] Defendants contend their removal was timely filed within one year of the commencement of the action as required by 28 U.S.C. §1446(c) 3 because they took “immediate action” to remove the cause before the February 22, 2023 deadline when it became apparent that

the hearing on their motion to dismiss could not be rescheduled prior to the expiration of the one- year deadline. [ECF No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Martin v. Franklin Capital Corp.
546 U.S. 132 (Supreme Court, 2005)
Dean Humphrey v. Sequentia, Inc.
58 F.3d 1238 (Eighth Circuit, 1995)
Christiane Dalton v. Walgreen Company
721 F.3d 492 (Eighth Circuit, 2013)
Prempro Products Liability Litigation v. Wyeth
591 F.3d 613 (Eighth Circuit, 2010)
Alvin L. Phipps v. Guaranty Natl. Bank
417 F.3d 1006 (Eighth Circuit, 2005)
Elaine Robinson v. Pfizer, Inc.
855 F.3d 893 (Eighth Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Lenzenhuber v. Misonix, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/lenzenhuber-v-misonix-inc-moed-2023.